# AstraZeneca and Ionis Stocks Sink on Trial Miss and Analysts See an Overreaction

> **Open Intelligence Dossier** · First detected: 2026-07-09 17:07 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"AstraZeneca and Ionis Stocks Sink on Trial Miss and Analysts See an Overreaction" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include WSJ, Yahoo Finance, Reuters and CNBC. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| WSJ | AstraZeneca, Ionis Shares Slide After Wainua Misses Target in Heart Disease Trial | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxPU0dSaVRkN2pmY3lURW10RzVwYlRRNFFfcW90Vmg3SVRiUXFpTG1ON25fdWNsR1ZJdXNJS3NSQ1gwYVdNaDhfRzlZTnRyTGY0M1l6UGxQS1BrZnQxZTN4bE1rak1zNGJtMzRMcUVCbVlzWVlmTHBWeXdxb01iVFJtZWFGbTJkeGczVk12Y2NHbTVvd25VZ01mQnhtM0l6OF81VUE?oc=5) |
| Yahoo Finance | IONS Stock Heads Toward Biggest Single-Day Slump In Over 5 Years – Retail Calls It ‘Opportunity Of A Lifetime’ | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxQeG9CdklqbEhhbTlBVDIwdDIzM05PMTB3VkFCQkxGc1l6c2Q1Q18tdnh1MFVmQzgtd3hhUnJpN1FLaEp2YmZTQ2IxRElKLWpnSHBWZ0Y5aG1zRld2ZkFhNDZ0ei1WZnotNmxxdEtvVVk1YUQ5UTBaUy1renhFT3Q1VUhEYkVZMlV2NlZpTG9sc0QzY1g4bGlRbEtOSmk?oc=5) |
| Reuters | AstraZeneca's Wainua fails key heart disease trial, shares tumble | [Source Link](https://news.google.com/rss/articles/CBMi3wFBVV95cUxNT1hfTDNWX2IwRHVtOFA5eGxKRWNuWjJOT3Vyd04yUXViOWRGUWxUMmxOVl9fZmV3Z0c4X3BpV2FrVFhRUHg2T1JRMDVaTndpZEZ6WnJ5SXo3c1l5N3BsTXphblBhOENEbG5ueUpxNFl3LUlWMGZXYkduaHNVZ0c3N0JqZTh4dWVpWTNDaUpHdFV6WWpVUUcxTHJfR2x6dHVvTl9KdW9GbVctTFFxbXEwMTdLQVBpQ3Y5dzE3RXdfczNYaDBCLUtMbGJRM0NvU2V3bE9LMlcyNGtpazF5Y21r?oc=5) |
| CNBC | AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxPMDQyN2hzSzZrYVFOY3F1RUtzSENYRlUyZk5zaHBZVERYQVY1V0UwN2thZXNqQW5vdXctUFR4emVhVjdSaGt0WjdIMFMwZ1A3LXYzczFpWkJ5TDIxd0E4RGNfYzR1SndVU3lXcm9yUFhZT0c5MExOM0xkRjl5VGJjSS1NN2jSAYoBQVVfeXFMT1J2UFFLZ2huendrTThlUnVkTU4zUHFMd3dfMVJyYmxSSVNaanBmbFNELTVGMjZuVGlnWk1sQThWMmlaVUNZTFBNblRGWTBSb1NGeXBacW9hamlGNjFKZnB5V2VmMlVfYjRsQjlZdkZJM2RxUGpHX0MyMXJmUTM0ZGtzWVlEZ2RtcVhn?oc=5) |
| Fierce Pharma | AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxNYnIxNnFVb29FWjVvTHBlT2Njd0Jjb29ZUEtxVXlfck8yOGJTcG4zcFVqaDlKX3BMMFlDcG9uUVBvUWctWnFoT0Y3OGJCYlFQQkxDRVJ3dlJtWFc0cGMyTVRfLWVJckc4VjA1OTRvcnV2UkFlNTZtX0Z0OW1hdUxmcFhtMjdENWdXT2gzWjVLbWJScHZ6SWNGMWY3bHoyQQ?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-09/astrazeneca-and-ionis-stocks-sink-on-trial-miss-and-analysts-see-an-overreaction*